American International Group, Inc. Sage Therapeutics, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$18.62 - $26.95 $4,170 - $6,036	-224 Reduced 0.85%	26,055 $488,000
Q4 2023 Feb 13, 2024	SELL	$17.1 - $22.26 $1,812 - $2,359	-106 Reduced 0.4%	26,279 $569,000
Q3 2023 Nov 13, 2023	BUY	$16.75 - $48.98 $15,711 - $45,943	938 Added 3.69%	26,385 $543,000
Q2 2023 Aug 04, 2023	BUY	$40.65 - $59.54 $12,398 - $18,159	305 Added 1.21%	25,447 $1.2 Million
Q1 2023 May 12, 2023	BUY	$37.27 - $46.57 $18,672 - $23,331	501 Added 2.03%	25,142 $1.05 Million
Q4 2022 Feb 10, 2023	SELL	$32.2 - $43.61 $2,898 - $3,924	-90 Reduced 0.36%	24,641 $939,000
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $11,298 - $15,144	350 Added 1.44%	24,731 $968,000
Q2 2022 Aug 12, 2022	BUY	$27.52 - $37.99 $656,186 - $905,833	23,844 Added 4440.22%	24,381 $788,000
Q1 2022 May 13, 2022	SELL	$30.71 - $45.71 $460 - $685	-15 Reduced 2.72%	537 $18,000
Q4 2021 Feb 11, 2022	SELL	$37.06 - $47.11 $741 - $942	-20 Reduced 3.5%	552 $23,000
Q3 2021 Nov 12, 2021	SELL	$40.26 - $57.37 $2,818 - $4,015	-70 Reduced 10.9%	572 $25,000
Q2 2021 Aug 13, 2021	SELL	$54.88 - $79.29 $548 - $792	-10 Reduced 1.53%	642 $36,000
Q1 2021 May 07, 2021	SELL	$70.65 - $96.76 $4,027 - $5,515	-57 Reduced 8.04%	652 $49,000
Q4 2020 Feb 12, 2021	SELL	$58.41 - $89.06 $408 - $623	-7 Reduced 0.98%	709 $61,000
Q3 2020 Nov 04, 2020	SELL	$41.13 - $62.45 $287 - $437	-7 Reduced 0.97%	716 $44,000
Q2 2020 Aug 12, 2020	SELL	$25.95 - $43.15 $11,392 - $18,942	-439 Reduced 37.78%	723 $30,000
Q1 2020 May 04, 2020	SELL	$26.15 - $77.24 $549 - $1,622	-21 Reduced 1.78%	1,162 $33,000
Q4 2019 Feb 05, 2020	SELL	$60.18 - $154.77 $3,009 - $7,738	-50 Reduced 4.06%	1,183 $85,000
Q2 2019 Aug 13, 2019	BUY	$157.85 - $183.09 $27,308 - $31,674	173 Added 16.32%	1,233 $226,000
Q1 2019 May 06, 2019	SELL	$89.33 - $163.65 $3,394 - $6,218	-38 Reduced 3.46%	1,060 $169,000
Q2 2018 Aug 08, 2018	SELL	$140.36 - $175.76 $3.63 Million - $4.54 Million	-25,827 Reduced 95.92%	1,098 $172,000
Q1 2018 May 07, 2018	BUY	$152.15 - $192.33 $219,400 - $277,339	1,442 Added 5.66%	26,925 $4.34 Million
Q4 2017 Feb 09, 2018	BUY	$60.72 - $167.34 $140,202 - $386,388	2,309 Added 9.96%	25,483 $4.2 Million
Q3 2017 Nov 09, 2017	BUY	$61.4 - $88.52 $1.42 Million - $2.05 Million	23,174	23,174 $1.44 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account